| Outbreak of Candida auris in Spain: a comparison of antifungal activity by three methods with published data AC Ruiz-Gaitán, E Cantón, ME Fernández-Rivero, P Ramírez, J Pemán International journal of antimicrobial agents 53 (5), 541-546, 2019 | 39 | 2019 |
| In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species A Valentín, E Cantón, J Pemán, ME Fernandez-Rivero, MA Tormo-Mas, ... Journal of Antimicrobial Chemotherapy 71 (12), 3449-3452, 2016 | 25 | 2016 |
| Activity of amphotericin B and anidulafungin combined with rifampicin, clarithromycin, ethylenediaminetetraacetic acid, N-acetylcysteine, and farnesol against Candida … ME Fernández-Rivero, JL Del Pozo, A Valentín, AM De Diego, J Pemán, ... Journal of Fungi 3 (1), 16, 2017 | 21 | 2017 |
| In vitro antifungal activity of ibrexafungerp (SCY-078) against contemporary blood isolates from medically relevant species of Candida: A european study G Quindós, K Miranda-Cadena, R San-Millán, K Borroto-Esoda, E Cantón, ... Frontiers in cellular and infection microbiology 12, 906563, 2022 | 17 | 2022 |
| Bacillus licheniformis as a cause of a deep skin abscess in a 5-year-old girl: an exceptional case following a plant thorn injury JR Yuste, SE Franco, C Sanders, S Cruz, ME Fernández-Rivero, G Mora Journal of Microbiology, Immunology and Infection 5 (49), 819-821, 2016 | 9 | 2016 |
| Activity of amphotericin B and anidulafungin, alone and combined, against Candida tropicalis biofilms developed on Teflon® and titanium ME Fernández-Rivero, JL Del Pozo, A Valentín, V Fornes, ... Revista Iberoamericana de Micologia 34 (3), 175-179, 2017 | 5 | 2017 |
| Time-kill assays of amphotericin B plus anidulafungin against Candida tropicalis biofilms formed on two different biomaterials ME Fernández-Rivero, JL Del Pozo, P Ramírez, E Valentín, A Ruiz-Gaitán, ... The International Journal of Artificial Organs 41 (1), 23-27, 2018 | 4 | 2018 |
| Estudio de la formación de la biopelícula de Candida spp. y evaluación de nuevas combinaciones farmacológicas ME Fernández-Rivero | 1 | 2017 |
